Toward a Pharmacophore for Kinase Frequent Hitters
- 12 October 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (23), 5616-5619
- https://doi.org/10.1021/jm049793g
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- CDK versus GSK-3 Inhibition: a Purple Haze No Longer?Chemistry & Biology, 2003
- An efficient proteomics method to identify the cellular targets of protein kinase inhibitorsProceedings of the National Academy of Sciences, 2003
- Kinases, Homology Models, and High Throughput DockingJournal of Medicinal Chemistry, 2003
- GefitinibNature Reviews Drug Discovery, 2003
- Issues and progress with protein kinase inhibitors for cancer treatmentNature Reviews Drug Discovery, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Intracellular Targets of PaullonesJournal of Biological Chemistry, 2002
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitorsChemistry & Biology, 2000